|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004482,
umls-concept:C0010583,
umls-concept:C0036421,
umls-concept:C0206062,
umls-concept:C0302350,
umls-concept:C0332271,
umls-concept:C0332281,
umls-concept:C0332283,
umls-concept:C0348016,
umls-concept:C0442027,
umls-concept:C0679199,
umls-concept:C1292734,
umls-concept:C1514923,
umls-concept:C1522326,
umls-concept:C2603343
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-6-5
|
|
pubmed:abstractText |
To evaluate the effects and safety of 6-month intravenous cyclophosphamide (CYC) followed by 18-month oral azathioprine (AZA) therapy in patients with systemic sclerosis (SSc) and worsening interstitial lung disease (ILD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
pubmed-author:AllanoreYannickY,
pubmed-author:BéreznéAliceA,
pubmed-author:BraunerMichelM,
pubmed-author:CabaneJeanJ,
pubmed-author:CohenPascalP,
pubmed-author:ConstansJoëlJ,
pubmed-author:CoudercLouis-JeanLJ,
pubmed-author:GuillevinLoïcL,
pubmed-author:HachullaEricE,
pubmed-author:KahanAndréA,
pubmed-author:KahnJean-EmmanuelJE,
pubmed-author:LaunayDavidD,
pubmed-author:Le GuernVéroniqueV,
pubmed-author:MahrAlfredA,
pubmed-author:MouthonLucL,
pubmed-author:PagnouxChristianC,
pubmed-author:RanqueBrigitteB,
pubmed-author:ValeyreDominiqueD
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1064-72
|
|
pubmed:meshHeading |
pubmed-meshheading:18464307-Administration, Oral,
pubmed-meshheading:18464307-Adult,
pubmed-meshheading:18464307-Antirheumatic Agents,
pubmed-meshheading:18464307-Azathioprine,
pubmed-meshheading:18464307-Cyclophosphamide,
pubmed-meshheading:18464307-Drug Therapy, Combination,
pubmed-meshheading:18464307-Female,
pubmed-meshheading:18464307-Humans,
pubmed-meshheading:18464307-Infusions, Intravenous,
pubmed-meshheading:18464307-Lung Diseases, Interstitial,
pubmed-meshheading:18464307-Male,
pubmed-meshheading:18464307-Middle Aged,
pubmed-meshheading:18464307-Pulse Therapy, Drug,
pubmed-meshheading:18464307-Respiratory Function Tests,
pubmed-meshheading:18464307-Retrospective Studies,
pubmed-meshheading:18464307-Scleroderma, Systemic,
pubmed-meshheading:18464307-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
|
|
pubmed:affiliation |
Paris Descartes University, Faculty of Medicine, Department of Internal Medicine and Reference Center for Necrotizing Vasculitides and Systemic Sclerosis, Cochin Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
